Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HI-TECH: Ticagrelor Endothelial Function Study
NCT02587260Phase 4Completed
- Sponsor
- Erasmus MC
- Start
- Dec 2015
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of ticagrelor in acute coronary syndrome (ACS), sponsored by Erasmus MC. Started Dec 2015; status: completed.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02587260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02587260.